Champions Oncology, Inc.CSBRNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
-7.3%/yr
vs -2.7%/yr prior
5Y CAGR
-9.4%/yr
Consistent
Acceleration
-4.6pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.65 | +17.4% |
| 2024 | 1.41 | +17.8% |
| 2023 | 1.19 | -42.4% |
| 2022 | 2.07 | -41.7% |
| 2021 | 3.55 | +31.4% |
| 2020 | 2.70 | -26.6% |
| 2019 | 3.69 | +59.3% |
| 2018 | 2.31 | +43.4% |
| 2017 | 1.61 | -41.7% |
| 2016 | 2.77 | - |